期刊文献+

羟基喜树碱抑制ECV304细胞的实验研究 被引量:2

Inhibition of Human Endothelial Cell by 10-Hydroxycamptothecin in Vitro
下载PDF
导出
摘要 目的 了解羟基喜树碱 (HCPT )对内皮细胞生长的影响 ,进而了解其对血管生成的抑制作用。方法 ECV 3 0 4细胞体外培养并检测不同浓度HCPT对细胞增殖率、形态、粘附功能的影响 ,采用流式细胞仪测定细胞凋亡指数和细胞周期。结果 终浓度为 4.0、7.5、15 .0、3 0 .0、60 .0ng/ml的HCPT对ECV 3 0 4的增殖抑制率分别为 6.7%、3 7.9%、69.5 %、87.4%、91.0 % ;7.5ng/ml和 15 .0ng/ml浓度处理的细胞凋亡率分别为 2 0 .0 %和 3 5 .1% ;细胞的形态和贴壁能力均有明显改变。 结论 HCPT可抑制内皮细胞增殖 ,并能使其形态改变 ,粘附功能下降 ,显示了其抗血管生成的潜能。 Objective To reveal the antiendothelial capability of 10 Hydroxycamptopthecin(HCPT),furthermore to reveal the antiangiogenic capability of HCPT.Methods ECV304 was cultured in medium supplemented with each HCPT dose(4.0 ng/ml,7.5 ng/ml,15.0 ng/ml,30.0 ng/ml,60.0 ng/ml).The cell number was estimated,the rate of inhibition was measured,and morphologic change was observed;the apoptotic rate of cell was tested by a flow cytometry.Results The rate of inhibition (6.7%,37.9%,69.5%,87.4%,91.0%) was correlated with the concentration of HCPT;the apoptotic rate (20.0%,35.1%) was significantly different from the normal(2.2%)( P <0.001),cell morphology and adhesive capability were significantly changed.Conclusion The study has shown the antiendothelial and antiangiogenic capability of HCPT in vitro.
出处 《实用癌症杂志》 2002年第6期580-582,共3页 The Practical Journal of Cancer
关键词 实验研究 羟基喜树碱 内皮细胞 血管生成 流式细胞仪 肿瘤 hydroxycamptothecin Endothelial cell Angiogenesis
  • 相关文献

参考文献8

  • 1[1]Kerbel RS. Tumor angiogenesis: past, present and the near future [J]. Carcinogenesis, 2000,21 (3): 505.
  • 2[2]Baguley BC, Holdaway KM, Thomsen LL, et al. Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine:evidence for a vascular mechanism[J]. Eur J Cancer, 1991,27(4) :482.
  • 3[3]Kachel DL,Martin WJ.Cyclophosphamidine-induced lung toxcity: mechanism of endothelial cell injury [J]. Pharmacol Exp Ther, 1994,268 (1) : 42.
  • 4[4]Vacca A, Iurlaro M, Ribatti D, et al. Antiangiogenesis is produced by nontoxic doses of vinblastine [J]. Blood,1999,94(12) :4143.
  • 5[5]Iurlaro M,Vacca A, Minischetti M,et al. Antiangiogenesis by cyclosporine[J]. Exp Hematol, 1998,26(13): 1215.
  • 6[6]
  • 7[7]Thompson WD, Li WW, Maragoudakis. The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies [J]. J Pathol, 1999,187 (5): 503.
  • 8[8]Folkman J. Tumor angiogenesis[M]. In: Holland JF, Bast RC, Morton DL, eds. Cancer medicine. ed 4. Baltimore:Williams & Wilkins, 1997:181.

同被引文献11

  • 1Kerbel BS. Tumor angiogenesis:past, present and the near future[J].Carcinogenesis, 2000, 21(3) :505 - 515.
  • 2Baguley BC, Holdaway KM, Thomsen LL, et al. Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism[J]. Eur J Cancer, 1991, 27(4) :482 - 487.
  • 3Ribatti D, Vacca A, Roncali L, et al. The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis[ J] .In J Devel Biol, 1996, 40(6):1189-94.
  • 4Folkman J. Tmor angiogenesis[M]. In: Holland JF, Bast RC, Morton DL, eds. Cancer medicine, ed 4. Baltimore: Williams & Wilkins,1997. 181 - 204.
  • 5司徒镇强.细胞培养[M].西安:世界图书出版社,2000.186.
  • 6孙立人,洪恂,丁绪亮,等.中药大辞典[M].北京:人民卫生出版社,2001:361.
  • 7赵小娟 党高潮 贺浪冲.用细胞膜色谱法筛选研究淫羊覆地下部分有效成分.分析化学,2002,30(1):74-75.
  • 8SIAN E, Hughes. Functional characterization of The spontaneously transformed human umbilical vein endothelial cell line ECV304: use in an in vitro model of angiogenesis[J].Experimental cell Research, 1996,225(1), 171-185.
  • 9闫彦芳,张壮,孙塑伦,王硕仁,何丽云,范吉平,朱陵群.三七总皂苷及其主要成分对血管内皮细胞缺氧损伤的保护作用[J].中国实验方剂学杂志,2002,8(1):34-37. 被引量:58
  • 10周幽心,黄煜伦,许期年,叶明,孙成法,周岱.雷公藤单体体外抑制胶质瘤细胞的实验研究[J].癌症,2002,21(10):1106-1108. 被引量:48

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部